R. Cheˆne6ert, D. Caron / Tetrahedron: Asymmetry 13 (2002) 339–342
341
3.6. (1S,5R)-(−)-1,5-Dimethyl-6,8-dioxabicyclo[3,2,1]-
octane or (1S)-(−)-frontalin 10
3.4. (R)-2-(4-Acetoxymethyl-4,5-dihydroxypentyl)-2-
methyl-1,3-dioxolane 5
A 1 M solution of lithium triethylborohydride in
THF (4 mL) was added to a cold (0°C) solution of
tosylate 7 (45 mg, 0.144 mmol) in dry THF. The
mixture was heated at reflux for 3 h. The mixture
was allowed to cool to room temperature and then
poured into ice-water (3 mL). The solution was aci-
dified with 1N HCl and extracted with ether. The
extracts were washed with 1N HCl, saturated
NaHCO3, water, dried (MgSO4), and concentrated
without the application of heat. The crude product
was purified by flash chromatography (hexane) to
yield (−)-frontaline 10 (19.5 mg, 95%) as a colorless
oil. [h]2D3 −52.0 (c 0.5, ether); lit.:10 [h]2D0 −52 (c 1,
ether). Spectroscopic data were identical to those
reported in the literature.
Compound 4 (302 mg, 1.37 mmol) was dissolved in
,
35 mL of dry benzene containing 300 mg of 4 A
molecular sieves. Vinyl acetate (675 mL, 7.32 mmol)
and crude Pseudomonas sp. lipase (700 mg) were
added and the mixture was stirred for 1.5 h at room
temperature; it was then filtered and the solids were
washed with ether. The solvents were evaporated and
the crude product was purified by flash chromatogra-
phy (ethyl acetate–hexane, 1/1, to ethyl acetate–
methanol, 4/1) to provide monoester 5 (160 mg, 45%)
and the corresponding diester 6 (232 mg, 55%). Com-
pound 5: [h]2D3 −2.6 (c 2.3, acetone); IR (neat) 3380,
2930, 2875, 1712, 1450, 1368, 1235, 1138, 1030 cm−1;
1H NMR (CDCl3) 4.12 (d, J=11.5 Hz, 1H), 4.01 (d,
J=11.5 Hz, 1H), 3.92 (m, 4H), 3.48 (d, J=11.5 Hz,
1H), 3.42 (d, J=11.5 Hz, 1H), 2.57 and 2.67 (br s,
2H), 2.09 (s, 3H), 1.63 (m, 2H), 1.48 (m, 4H), 1.29 (s,
3H); 13C NMR (CDCl3) 171.5, 109.8, 73.3, 66.4, 65.2,
64.5, 39.3, 34.2, 23.6, 20.7, 17.2; HRMS (CI, NH3)
calcd for C12H26O6N (M+NH4): 280.1760. Found:
280.1764. Compound 6: IR (neat) 3468, 2959, 2884,
1743, 1464, 1436, 1376, 1236, 1044 cm−1; 1H NMR
(CDCl3) 4.04 (m, 4H), 3.91 (m, 4H), 2.08 (s, 6H),
1.64 (m, 2H), 1.53 (m, 4H), 1.29 (s, 3H); 13C NMR
(CDCl3) 170.8, 109.7, 72.2, 66.6, 64.5, 39.3, 34.6,
23.7, 20.7, 17.0; HRMS (CI, NH3) calcd for
C14H28O7N (M+NH4): 322.1866. Found: 322.1869.
3.7. (R)-2-(4-Acetoxymethyl-4,5-epoxypentyl)-2-methyl-
1,3-dioxolane 8
Triethylamine (1.5 mL, 10.8 mmol) and 4-(N,N-
dimethylamino)pyridine (5 mg) were added to a solu-
tion of diol 5 (156 mg, 0.595 mmol) in anhydrous
methylene chloride (10 mL). Tosyl chloride (370 mg,
1.94 mmol) was added and the solution was stirred at
room temperature for 7 days. Ether (100 mL) was
added and the organic phase was washed with 1N
HCl, saturated NaHCO3, brine, dried (MgSO4) and
concentrated. The crude product was purified by flash
chromatography (hexane–ethyl acetate–triethylamine,
74/25/1) to give 8 as a colorless oil (130 mg, 90%).
[h]2D3 −6.0 (c 1.84, acetone); IR (neat) 3053, 1743,
1241, 1227, 1041 cm−1; 1H NMR (CDCl3) 4.24 (d,
J=12 Hz, 1H), 3.93 (d, J=12 Hz, 1H), 3.87 (m, 4H),
2.69 (d, J=5 Hz, 1H), 2.65 (d, J=5 Hz, 1H), 2.02 (s,
3H), 1.43–1.80 (m, 6H), 1.22 (s, 3H); 13C NMR
(CDCl3 170.5, 110.1, 66.3, 65.1, 57.5, 50.4, 39.6, 32.5,
23.9, 20.5, 19.8; HRMS (CI, NH3) calcd for C12H21O5
(M+H): 245.1389. Found: 245.1395.
3.5. (1S,5R)-5-Methyl-1-para-toluenesulfonyloxymethyl-
6,8-dioxabicyclo[3,2,1]octane 7
A solution of compound 5 (112.5 mg, 0.430 mmol),
p-toluenesulfonyl chloride (163.6 mg, 0.859 mmol)
and 4-dimethylaminopyridine (10 mg) in dry pyridine
(2 mL) was stirred for 24 h at room temperature.
Ether (100 mL) was added and the organic layer was
washed with a 1N HCl solution (3×100 mL), with a
saturated NaHCO3 solution (3×100 mL) and with
brine (3×100 mL), dried, and evaporated. A mixture
of the crude tosylate (153 mg, 0.367 mmol), water
(100 mL), p-toluenesulfonic acid monohydrate (105
mg, 0.552 mmol) and CH2Cl2 (2 mL) was stirred at
room temperature for 72 h. Ether (50 mL) was added
and the organic layer was washed with saturated
NaHCO3 (3×50 mL), water (3×50 mL), dried
(MgSO4) and concentrated. The crude product was
purified by flash chromatography (ethyl acetate–hex-
ane, 1/4 to 4/1) to give tosylate 7 (106.6 mg, 93%) as
a white solid. Mp 103–104°C (from hexane); [h]D23
−18.2 (c 1.32, CHCl3); lit.10: mp 110°C, [h]D20 −20 (sol-
vent and concentration not specified); IR (KBr) 1360,
1193, 1174, 975, 843, 819, 556, 524 cm−1; 1H NMR
(CDCl3) 7.72 (d, J=8 Hz, 2H), 7.28 (d, J=8 Hz,
2H), 3.98 (d, J=10 Hz, 1H), 3.96 (d, J=10 Hz, 1H),
3.82 (d, J=7 Hz, 1H), 3.44 (d, J=7 Hz, 1H), 2.38 (s,
3H), 1.46–1.87 (m, 6H), 1.30 (s, 3H); 13C NMR
(CDCl3) 144.9, 132.5, 129.7, 127.9, 109.0, 80.1, 71.6,
70.5, 34.4, 29.0, 24.1, 21.5, 17.0.
3.8. (S)-2-(4,5-Dihydroxy-4-methylpentyl)-2-methyl-1,3-
dioxolane 9
Epoxide 8 (44.8 mg, 0.183 mmol) was dissolved in
anhydrous THF (1 mL) under N2, LiAlH4 (28 mg,
0.74 mmol) was added and the mixture was stirred at
room temperature for 1 h. Ether (20 mL) was added
and the reaction was quenched with sodium sulfate
monohydrate. The mixture was filtered through Celite
and the solvent was evaporated. The crude product
was purified by flash chromatography (ethyl acetate–
hexane, 1/4, to pure ethyl acetate) to give 9 as a
colorless oil (33.4 mg, 90%). [h]2D3 −2.1 (c 1.2, ether);
lit.:11 [h]2D5 −1.8 (c 1.2, ether); IR (neat) 3583, 3410,
1378, 1152, 1055 cm−1; 1H NMR (CDCl3) 3.55 (m,
4H), 3.34 (d, J=11 Hz, 1H), 3.28 (d, J=11 Hz, 1H),
2.47–2.65 (br s, 2H), 1.32–1.76 (m, 6H), 1.32 (s, 3H),
1.08 (s, 3H); 13C NMR (CDCl3) 110.2, 72.7, 70.0,
64.6, 40.2, 39.1, 24.0, 23.4, 18.6.